$BOLD Audentes Therapeutics, Inc. Insiders

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Audentes Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of current and past insiders in Audentes Therapeutics, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.

Audentes Therapeutics, Inc. Insiders

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
5AM Partners III, LLC10% Owner64,4311,019,943Apr 26 2017
Conner Edward R.SVP, Chief Medical Officer00Jan 15 2020
Flynn James E10% Owner535,9968,484,817Jul 25 2016
Goldberg Mark AlanDirector00Jan 15 2020
GRAY JOHN T.SVP, Chief Scientific Officer871,377Oct 02 2018
Holles Natalie C.President and COO00Jan 15 2020
Jarrett JenniferDirector00Jan 15 2020
LANGE LOUIS GDirector00Jan 15 2020
Meltz Mark ASVP, General Counsel00Jan 15 2020
Morrison Scott WDirector00Jan 15 2020
Mosbrooker EricSVP, Chief Commercial Officer00Jan 15 2020
Nagler DavidSVP, HR & Corp. Affairs4,70074,401Jun 22 2018
NEWMAN MARYSVP, Regulatory Affairs66010,448Nov 16 2018
ORBIMED ADVISORS LLC10% Owner3,638,00057,589,540Mar 12 2018
PARMAR KUSHDirector00Jun 08 2018
Patterson Matthew RChief Executive Officer00Jan 15 2020
PRASAD SUYASHSenior VP & Chief Med Officer17,479276,693Jun 07 2019
Schuetz Thomas J.Director00Jan 15 2020
SILVERSTEIN JONATHANDirector852,10513,488,822Aug 25 2016
Smith JulieDirector00Jan 15 2020
Soloway Thomas PExecutive Vice President, CFO00Jan 15 2020
SQUINTO STEPHEN PDirector00Oct 10 2017
Versant Ventures IV, LLC10% Owner1,081,47717,119,781Jul 25 2016
Woiwode ThomasDirector1,081,47717,119,781Aug 25 2016